ALKBH5 and neoplasm: These EVs transferred circEML4 into tumor cells, where it interacted with ALKBH5, restricted its nuclear localization, and increased global m6A levels, thereby promoting malignant progression via the SOCS2/JAK-STAT pathway (52) (Figure 3).